Healthcare - Biotechnology - NASDAQ - US
$ 0.151
-4.37 %
$ 5.95 M
Market Cap
-0.13
P/E
INCOME STATEMENT
0
REVENUE
-50.7 M
OPERATING INCOME
-51.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Viracta Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 492 K |
| Gross Profit | -492 K |
| Operating Expenses | 50.7 M |
| Operating Income | -50.7 M |
| Other Expenses | 365 K |
| Net Income | -51.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0.1 | 2.1 | 0.2 | 0.7 | 2.5 | 3.1 | 5.7 | 8.0 | 3.8 | 5.0 | 33.1 K | 3.8 | 5.4 | 9.7 | 13.7 | 16.5 |
| GROSS PROFIT | |||||||||||||||||||
| Cost Of Revenue | 0.5 | 0.2 | 0.2 | 32 K | 0 | (0.9) | 9 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.5) | (0.2) | (0.2) | 88 K | 2.1 | 1.1 | 0.7 | 2.5 | 3.1 | 5.7 | 8.0 | 3.8 | 5.0 | 33.1 K | 3.8 | 5.4 | 9.7 | 13.7 | 16.5 |
| OPERATING INCOME | |||||||||||||||||||
| Operating Expenses | 50.7 | 50.6 | 25.8 | 18.8 | 25.4 | 25.9 | 35.1 | 39.0 | 42.3 | 50.8 | 39.7 | 38.4 | 30.9 | 21.4 | 21.0 | 37.8 | 49.6 | 47.9 | 44.4 |
| Selling, General and Administrative Expenses | 17.3 | 24.3 | 15.4 | 5.3 | 9.9 | 11.3 | 13.5 | 16.1 | 18.6 | 23.1 | 10.8 | 9.2 | 8.3 | 7.0 | 7.7 | 11.5 | 13.6 | 12.3 | 8.3 |
| Research and Development Expenses | 33.4 | 26.3 | 23.9 | 13.5 | 15.4 | 14.6 | 21.5 | 22.9 | 23.7 | 27.7 | 28.9 | 29.2 | 22.6 | 14.4 | 13.2 | 26.3 | 36.1 | 35.6 | 36.2 |
| Operating Income | (50.7) | (50.6) | 62.5 | (18.8) | (23.3) | (25.7) | (34.4) | (36.5) | (39.3) | (41.3) | (31.7) | (42.1) | (19.8) | (24.6) | (40.2) | (37.0) | (38.6) | (30.8) | (26.8) |
| PRE-TAX INCOME | |||||||||||||||||||
| Interest Income Expense | 3.7 | 0.6 | 0.5 | 0.2 | 0.5 | 1.2 | 1.4 | 1.7 | 0.9 | 1.7 | 2.9 | 1.9 | 0.3 | 0 | 1.19 K | 0.2 | 0.2 | 0.5 | 0.7 |
| Total Other Income | (0.4) | 1.4 | (75.5) | (0.2) | 42 K | (0.9) | (1.0) | (1.6) | 2.6 | 2.0 | (2.8) | (9.3) | 5.7 | (24 566.1) | (23.0) | 1.0 | (1.6) | 3.4 | 0.4 |
| Pre-Tax Income | (51.1) | (49.2) | (114.8) | (19.0) | (23.3) | (26.6) | (35.5) | (38.0) | (36.7) | (43.0) | (34.6) | (44.0) | (20.1) | (24.6) | (63.2) | (37.2) | (40.1) | (30.8) | (26.8) |
| NET INCOME | |||||||||||||||||||
| Tax Provision | 0 | 0.6 | 88.3 | 0.2 | 0.5 | 1.2 | 1.4 | 1.7 | 0.9 | 1.7 | 2.9 | 1.9 | 0.3 | (21 077.2) | 1.19 K | 0.2 | 0.2 | 0.5 | 0.7 |
| Net Income | (51.1) | (49.8) | (203.1) | (19.2) | (23.3) | (26.6) | (35.5) | (38.0) | (36.7) | (44.7) | (37.5) | (45.8) | (20.4) | (24.6) | (63.2) | (37.4) | (40.3) | (31.2) | (27.5) |
| EPS | 1.32 | 1.32 | 6.37 | 207 | 9.37 | 26.2 | 50.6 | 84.8 | 106 | 44.7 | 43.1 | 57.1 | 26.4 | 59.3 | 662 | 391 | 449 | 405 | 431 |